NCT00329745View on ClinicalTrials.gov

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

PHASE3CompletedINTERVENTIONAL
Enrollment

8,687

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

Rotarix™

Oral administration, 2 doses

BIOLOGICAL

Placebo

Oral administration, 2 doses

Trial Locations (4)

119074

GSK Investigational Site, Singapore

228510

GSK Investigational Site, Singapore

229899

GSK Investigational Site, Singapore

308433

GSK Investigational Site, Singapore

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY